ClinicalTrials.gov
public full text
Public Domain
The Influence of IgY Max on Inflammatory Markers and the Gut Microbiome
The purpose of this study is to determine the optimal dose of IgY as assessed by changes in the inflammatory marker, C-reactive protein and investigate the effect of IgY on the gut microbiome as assessed by 16s RNA sequencing of fecal samples.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Protease-serpin-microbiome interactions in inflammatory bowel disease: toward integrated biomarkers of gut health.#646466
- Protease-serpin-microbiome interactions in inflammatory bowel disease: toward integrated biomarkers of gut health.#645296
- Chronic intestinal immune activation reveals separable impacts of inflammation and barrier loss on hallmarks of ageing#1107047
- A Metagenome-wide Association Study of Gut Microbiota in Gastrointestinal Non-Hodgkin's Lymphoma Patients#885738
- A metagenomic analysis of the gut microbiota in a mouse model of fish allergy.#975581
Record · ID 914750
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive